F18.90
Inhalant use, unspecified, uncomplicated
Clinical Classification Guidelines
Medical Intelligence & Overview
Inhalant use refers to the act of breathing in substances that contain chemicals, often for their mind-altering effects. The ICD-10 code F18.90 specifically identifies cases where inhalant use has been documented but is considered uncomplicated, meaning there are no additional complications such as poisoning or chronic health issues at the time of diagnosis. While inhalant use may seem harmless to some, it can pose significant health risks, especially with repeated or long-term exposure. This overview aims to shed light on what inhalant use entails, its causes, common symptoms, and general approaches to diagnosis and management.
Causes & Symptoms
Clinical Causes: Curiosity, especially among adolescents and teenagers seeking new experiences Peer pressure and social influences encouraging experimentation Mental health issues, including depression or anxiety, leading individuals to seek relief through substance use Availability and accessibility of inhalant substances in the environment Lack of awareness about the dangers of inhalant use Familial or environmental factors that promote substance experimentation
Key Symptoms: Dizziness or lightheadedness Euphoric feelings or a feeling of intoxication Headaches or nausea Slurred speech and lack of coordination Visual or hearing disturbances Respiratory issues like coughing or shortness of breath Unusual odors on the breath or clothing that indicate inhalant substances
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a healthcare provider conducting a comprehensive review of the patient's medical history and current symptoms. Physical examinations may reveal signs consistent with inhalant use. Laboratory tests, such as blood or urine screens, can detect specific chemicals associated with inhalants. Mental health evaluations are often performed to assess any underlying issues contributing to the behavior. It's important to distinguish uncomplicated inhalant use from more severe forms involving intoxication or poisoning, which may require more urgent interventions. The use of the ICD-10 code F18.90 indicates that the inhalant use has been identified but is currently uncomplicated, with no evidence of acute toxicity or chronic health damage.
Treatment Protocols: Managing inhalant use generally involves a multidisciplinary approach focusing on education, counseling, and behavioral therapies. Interventions may include: - Educational programs highlighting the dangers of inhalant use - Counseling or psychotherapy to address underlying psychological or social factors - Support groups for individuals struggling with substance use - Monitoring for signs of escalation or development of complications Long-term treatment may involve addressing related mental health issues and developing coping strategies to prevent relapse. In some cases, referral to specialized addiction treatment centers might be recommended, especially if use persists or worsens over time.
Clinical Advice & FAQs
Billing Guidance
Is F18.90 a billable ICD-10 code?
Yes, F18.90 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.90?
Clinical documentation must specify the nature of Inhalant use, unspecified, uncomplicated and any associated comorbidities for accurate reporting.
Cite this Clinical Reference